Virginia Tech® home

In Person Seminar: Computing Conscious Experience: Reinforcement Learning, Neuromodulatory Systems, and Dynamic Changes in Phenomenal Experience.

Insert your title here

Kenneth T. Kishida, Ph.D.

Kenneth T. Kishida, Ph.D.

Associate Professor
Physiology and Pharmacology
Wake Forest University School of Medicine

In Person Seminar: Computing Conscious Experience: Reinforcement Learning, Neuromodulatory Systems, and Dynamic Changes in Phenomenal Experience

Date: Nov. 8, 2023

Time:  9:30 a.m.

About this Seminar

Dr. Kishida and his research team seek a theoretical account of ‘how conscious phenomenal experience comes to be’. Such a theory should be founded in neurobiological and behavioral data and ought to yield engineerable solutions for the spectrum of psychiatric and neurological burdens that plague human mental (and physical) experience. Recent advances in the ability to monitor dopamine release in the human brain (with sub-second temporal resolution) while participants express adaptive behavior and report how they subjectively feel suggest a novel hypothesis about how the contents and context of conscious experience come to be laden with subjective value and emotional affect. The team hypothesizes a “Dynamic Affective Core”, which combines ideas about network representations of the contents and context of experience with signals derived from computational reinforcement learning theory that can add and dynamically modulate the subjective phenomenal value of constantly changing information states. Dr. Kishida will present a brief overview of the supporting neuroscientific data including intracranial sub-second measurements of dopamine release in humans and computational principles involved, but also discuss gaps in our understanding and future directions. The lab hopes to circumscribe the challenge of characterizing the neurobiological mechanisms that give rise to conscious experience in humans and provide a path forward for investigating disorders of human experience like mood disorders and substance use and addiction disorders.

You May Also Be Interested In...

  • Home Item
    Social Learning in Borderline Personality Disorder
    Social Learning in Borderline Personality Disorder , home

    April 4, 2025, 11:00 a.m. | Sarah Fineberg, M.D., Ph.D., Assistant Professor, Department of Psychiatry, Yale School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Center for Human Neuroscience Research

  • Home Item
    Bringing Precision Medicine to Psychiatry
    Bringing Precision Medicine to Psychiatry , home

    April 10, 2025, 5:30 p.m. (Reception at 5 p.m.) | Jordan Smoller, M.D., Sc.D., Massachusetts General Hospital Trustees Endowed Chair in Psychiatric Neuroscience; Professor of Psychiatry, Harvard Medical School; Professor of Epidemiology, T.H. Chan Harvard School of Public Health; Director, Psychiatric and Neurodevelopmental Genetics Unit, Massachusetts General Hospital | Maury Strauss Distinguished Public Lecture

  • Home Item
    Extracellular Vesicles in the Pathogenesis, Diagnosis and Treatment of the Heart
    Extracellular Vesicles in the Pathogenesis, Diagnosis and Treatment of the Heart , home

    April 11, 2025, 11:00 a.m. | Susmita Sahoo, Ph.D., Associate Professor, Department of Medicine and Cardiology, Icahn School of Medicine at Mount Sinai | Co-Sponsored by the Fralin Biomedical Research Institute Center for Vascular and Heart Research

  • Home Item
    A Human-Centric View of Cerebellar Development
    A Human-Centric View of Cerebellar Development , home

    April 18, 2025, 11:00 a.m. | Kathleen Millen, Ph.D., Professor, Department of Pediatrics/Genetics, Associate Director and Principal Investigator, Seattle Children's Hospital Research Institute, The University of Washington School of Medicine | Co-Sponsored by the Center for Neurobiology Research, Fralin Biomedical Research Institute

  • Home Item
    Molecular and Neurobiological Studies in Rett Syndrome and Other MECP2 Disorders
    Molecular and Neurobiological Studies in Rett Syndrome and Other MECP2 Disorders , home

    May 1, 2025, 5:30 p.m. (Reception at 5 p.m.) | Huda Zoghbi, M.D., Professor, Pediatrics, Molecular and Human Genetics, Neuroscience, and Neurology; Director, Jan and Dan Duncan Neurological Research Institute, Baylor College of Medicine; Member, National Academy of Medicine | Maury Strauss Distinguished Public Lecture

  • Home Item
    A Novel Bispecific Antibody to Target the Brain Tumor Microenvironment
    A Novel Bispecific Antibody to Target the Brain Tumor Microenvironment , home

    May 2, 2025, 11:00 a.m. | Khuson Yun, Ph.D., Associate Professor, Department of Neurology, Houston Methodist Chair, Neurodegenerative Disease Research, Houston Methodist Research Institute, Weill Cornell Medical College | Co-Sponsored by the Fralin Biomedical Research Institute Cancer Research Center – Roanoke